🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

👏Today's #SOHO2024 plenary session featured an insightful presentation titled "Myelodysplastic Neoplasms and the Challenge of Therapeutic Targets: Epigenetics, Genetics, or Inflammation?" by Valeria Santini of Università di Firenze! #MDSsm

Today at #SOHO2024: Valeria Santini, of Università di Firenze, presented on "Myelodysplastic Neoplasms and the Challenge of Therapeutic Targets" at the Plenary Session! #MPN Society of Hematologic Oncology (SOHO)

From the front page to the stage Valeria Santini is getting it done at #SOHO2024

UBA1 mutations were identified in 1% of patients with MDS and 7% of patients lacking myeloid mutations or established disease classification. ow.ly/2ALj50TmrCM #myeloidneoplasia

#MDS session IACH is 🔥 🔥 ! Amazing talks moderated by Valeria Santini Amer Zeidan MBBS,MHS ‏عامر زيدان

What progress has been made in the categorization and treatment of LR-MDS? 🤔 We caught up with Valeria Santini of Università di Firenze at #SOHO2024 to find out! Check out the insightful interview here: 👉 ow.ly/FtU450TpXhi 👈 #MDSsm #HemOnc Society of Hematologic Oncology (SOHO)

In his honor. The long journey of HSCT in multiple sclerosis. A huge emotion this morning at the ADWP&CTIWP joint meeting in Milan Annalisa Ruggeri raffaellagreco EBMT_Cellular_Therapy

🔬 Ready to shape the future of #HCT and #CellularTherapies? Time to choose your Abstract Topic for the 51st Annual Meeting of the EBMT, taking place in 📍 Florence next spring. #EBMT25 is your chance to present your research to a large panel of international experts and gain

To honor international MDS day , a great meeting with FISIM Italian colleagues like Matteo della Porta, Francesco Onida, Emanuele Angelucci, Ester Oliva…, discussion and get together, as well as the privilege of listening to the best European experts in MDS and share knowledge

For MDS World Awareness Day, share these words of HOPE with your friends and family: "You will have good days and bad days...but this will make you stronger than you will ever know." Watch here: aamds.org/webinar/mds-pa… to learn from other patients.

We can't wait for many exciting trial updates at #ASH24!😍 At #SOHO2024 a few months ago, Valeria Santini of Università di Firenze gave an update on the IMerge trial exploring imetelstat as a treatment for LR-MDS: 👉 ow.ly/anLv50U6eyp 👈 #MDSsm #HemOnc #CTSM #TrialUpdate

✨ What does it take to shift the standard of care in #MDS? Access practice-changing evidence that informs treatment individualization for patients with MDS. Learn from experts Drs. Guillermo Garcia-Manero (G Garcia-Manero), María Díez Campelo (María Díez Campelo), and Valeria Santini

Watch Guillermo Garcia-Manero, MD (G Garcia-Manero), María Díez Campelo, MD, PhD (María Díez Campelo) & Valeria Santini, MD (Valeria Santini) discuss the latest #MDS updates from #ASH2024 HealthTree Foundation - to participate, visit: bit.ly/T2024-MDS x.com/i/broadcasts/1…

PeerView G Garcia-Manero Valeria Santini HealthTree Foundation Starting right now 😊

Live from #ASH24, highlighting presentations by Guillermo Garcia-Manero, MD (G Garcia-Manero), María Díez Campelo, MD, PhD (María Díez Campelo), and Valeria Santini, MD (Valeria Santini) on the latest #MDS updates. Thrilled to partner with PeerView to share these insightful sessions!

Delighted to chat with Prof Valeria Santini and Sven about their study at #ASH24 ! #MDSsm #Aging ASH

More on immune dysfunction in myeloid malignances simona colla shares 👌🏼 data on irreversible dysfunction of clonal NK cells in MDS (early as CCUS), in part due to 🚫 NK synapse formation w/ loss of TET2 & DNMT3A #i4MDS MD Anderson Cancer Center Valeria Santini Shahram Kordasti #mdssm

🔝 Magistral intervención de Valeria Santini, de la Universidad de Florencia, sobre el manejo del #SMD de bajo riesgo y la incorporación de los nuevos #fármacos. #gesmd #HematoEnRed @sehh_es

Response to luspatercept therapy is predictable and prolongs overall survival of LR MDS patients. Valeria Santini 👉bit.ly/3FDsXPS

#EBMT25 | As always, it was a pleasure to speak with the wonderful Valeria Santini, who discussed the impact of the updated classification for MDS on the management of patients.🩸 Keep an eye out on our site for her interview!👀🎥 👉 VJHemOnc.com #BMTsm #MDSsm